(Q44226369)

1 December 2017

title

Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient (English)

1 reference

Isabelle Cardeau-Desangles

1 December 2017

1 reference

1 reference

1 reference

hepatitis E virus

1 reference

1 reference

series ordinal

4

object named as

Isabelle Cardeau-Desangles

1 reference

1 December 2017

7

Jacques Izopet

1 reference

Florence Legrand-Abravanel

1 December 2017

series ordinal

2

object named as

Florence Abravanel

1 reference

1 December 2017

8

Lionel Rostaing

1 reference

1 December 2017

1

Nassim Kamar

1 reference

1 December 2017

5

Jean Michel Mansuy

1 reference

1 December 2017

6

Hugo Weclawiak

1 reference

1 December 2017

3

Cyril Garrouste

1 reference

1 December 2017

language of work or name

English

0 references

publication date

20 May 2010

1 reference

Nephrology Dialysis Transplantation

1 December 2017

published in

1 reference

1 December 2017

volume

25

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

2792-2795

1 reference

Hepatitis E: an emerging infection in developed countries.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Persistent carriage of hepatitis E virus in patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Chronic hepatitis E with cirrhosis in a kidney-transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Chronic hepatitis E virus infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

Pegylated interferon -2a versus standard interferon -2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ282

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ282

1 reference

1 December 2017

1 reference